Brief: China Pharma - Unit Got Drug Supplementary Application Approval Notice For Candesartan Tablets By China's NMPA
09/08/2023 14:55
Aug 9 (Reuters) - China Pharma Holdings Inc CPHI.A :
* CHINA PHARMA - UNIT GOT "DRUG SUPPLEMENTARY APPLICATION
APPROVAL
NOTICE" FOR CANDESARTAN TABLETS BY CHINA'S NMPA
Source text for Eikon: ID:nPn2wg351a
Further company coverage: CPHI.A
Recent news on China Pharma Holdings
See all newsBrief: China Pharma - Not Aware Of Any Material Corporate Developments Explaining Recent Market Activity
Brief: China Pharma Says Co Knows Of No Events That Could Have Caused Unusual Market Activity
Brief: China Pharma Holdings Inc - NYSE American Contacts China Pharma Regarding Unusual Market Activity On May 12 And 13
Brief: China Pharma Holdings Files For Non-Timely 10-K With US SEC
Brief: China Pharma Holdings Inc. Announces 1-For-10 Reverse Stock Split